Anju Proudly Sponsors DIA MASC 2021 Forum

March 22-24, 2021 | Virtual Conference

Will we see you at DIA MASC this year? We sure hope so. Visit us in the exhibit area under Anju Software to check the latest news about our Medical Affairs product offerings or just to say hello to the team. Listen to our presentation on “Medical Affairs: from Support Function to Strategic Pillar.” This session will discuss how the Life Sciences industry is facing a fundamental transformation from a product orientation to an outcome orientation. You can find the presentation under networking events or at the Anju Software exhibit area. Only registered DIA attendees can view the presentation.

Introducing Anjumax – Medical Affairs eXperience

Anjumax provides an adaptive platform for the MAX (Medical Affairs eXperience) offering core deliverables and game-changing value. Included in this suite are IRMSmax, pubstratmax, Zephyr and ta-Scan. The platform’s AI-based analytical solution combined with data and application integration capabilities, serves the world-wide pharmaceutical, biotech and contract research Life Sciences Markets.

We look forward to “seeing” you this year in a virtual setting. Schedule a meeting now with one of our Medical Affairs Team members.


DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, by medical affairs professionals. This forum provides a comprehensive understanding of the regulatory and compliance environment directly affecting the daily activities of medical affairs and scientific communication professionals. Made up of multiple general and breakout sessions within three tracks covering medical communications, medical writing, and medical science liaisons, you can pick and choose which sessions to attend and create your own unique forum. You must be registered to attend the event.

Not attending, but would you like more information on Anju and how our technology solutions might help your organization? Please contact our Medical Affairs Team.

Want to stay up to date with our news?

To top